Fluticasone prop HFA 220 MCG 12GM
Ended Awarded
- Contract number
- SPE2DB25FQZPB
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,245
Award facts
- Contract value 100% obligated
- $16,245.25 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Fluticasone Propionate HFA 220 MCG inhalers (12-gram containers) with a firm fixed price contract value of $16,245.25. This is a non-set-aside competitive award with an ultimate completion date of September 10, 2025, and performance will be executed from the vendor's Corporate Office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999 comprehensive pharmaceutical supply vehicle running through December 2026 that enables the company to deliver a broad range of medications, vaccines, and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal vendor for military and veteran healthcare systems through multiple competitively awarded contracts with the Defense Logistics Agency. The company's extensive portfolio with DLA demonstrates capability in fulfilling diverse pharmaceutical procurement needs across therapeutic domains, including specialty medications, brand-name and generic drugs, and medical supplies. This particular delivery order for respiratory medication supports the agency's medical supply chain objectives and aligns with the company's established role as a primary vendor for defense healthcare procurement.
Quick answers
Who was awarded contract SPE2DB25FQZPB?
SPE2DB25FQZPB was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 9, 2025.
How much is contract SPE2DB25FQZPB worth?
The government has obligated $16,245 on SPE2DB25FQZPB.
Is contract SPE2DB25FQZPB an order under another contract?
Yes. SPE2DB25FQZPB is a delivery order under SPE2DB25D3021, an indefinite delivery contract.
Was contract SPE2DB25FQZPB competed?
The extent of competition for SPE2DB25FQZPB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award